Navigation Links
Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
Date:11/7/2012

JERUSALEM, November 7, 2012 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed using its oral insulin formulation, ORMD-0801, have been accepted for presentation at the 12th Annual Diabetes Technology Society Meeting.  The abstract, titled "Concomitant oral and subcutaneous insulin therapy toward stabilization of uncontrolled T1DM," will be presented by Oramed's Chief Scientific Officer, Dr. Miriam Kidron, during the poster session being held from 4pm to 6:30pm (EST), on Thursday, November 8th. The meeting will take place at the Bethesda North Marriott Hotel & Conference Center.

Type 1 Diabetes Mellitus (T1DM), formerly known as juvenile diabetes, affects both young and adult populations. T1DM makes up approximately 5-10% of diabetes cases, and approximately $2 billion of the estimated $15 billion global insulin market. In this form of the disease, an autoimmune reaction destroys the body's insulin-producing cells in the pancreas making its patients completely dependent upon insulin from an external source.

T1DM is occasionally associated with instability and unpredictability of glycemic readings, resulting in poor control of blood sugar.  In severe cases, this condition has a disruptive impact on patient quality of life, due to inadequate clinical solutions. The study to be presented at the Diabetes Technology Society Meeting, and conducted in 2010, evaluated the safety and stabilizing potential of concomitant oral and subcutaneous insulin therapy in volunteers diagnosed with unstable T1DM. Concomitant administration of Oramed's oral insulin formulation, ORMD-0801, and subcutaneous insulin proved safe and well tolerated.  In addition, support with ORMD-0801 led to more frequent blood glucose readings within the healthy range (< 70 mg/dL) and to fewer readings within the
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
7. Icahn Issues Statement Regarding Amylin Pharmaceuticals
8. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
11. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 NVSSoft, a ... been named a "Cool Vendor" by top IT research firm ... 2015". Gartner defines a "Cool Vendor" as a ... and intriguing. The report highlights that, "as innovation ... in emerging markets should look at local technologies and services, ...
(Date:5/6/2015)... 2015 3D Communications announced ... for helping pharmaceutical companies communicate the value of ... The newly expanded 3D Market Access ... helping companies develop and deliver their "Value Story". It ... engage critical stakeholders earlier in the "innovation-to-market" timeline, ...
(Date:5/6/2015)... --  GenSpera, Inc. (OTCQB: GNSZ) announced today that the ... application process in 17 countries and regions, including ... China , Brazil and ... resulting patent application will extend the exclusivity period for GenSpera,s ... lead drug candidate, mipsagargin, until 2033. This recent ...
Breaking Medicine Technology:UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 43D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... April 5, 2011 / PRNewswire / -- ... today that the U.S. Food and Drug Administration,s (FDA) ... approve Optimer,s investigational antibiotic DIFICID™ (fidaxomicin) for ... infection (CDI), a bacterial infection in the lining of ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... to release its first quarter 2011 financial results on Wednesday, ... financial markets.  The Company will also host a conference call ... 2011 to discuss its financial results and provide an update ...
Cached Medicine Technology:Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 2Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 3Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 4Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 5Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 6Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive ... it to the headlines of major publications world-wide. With ... and Hyundai ready to share their visions for the ... way for press to go behind the scenes and ... TU-Automotive said “This year we’re releasing a preview of ...
(Date:5/6/2015)... The 2015 STEMtech conference exhibition hall ... booth selection . Don’t miss this opportunity to ... and university decision-makers from around the country. , This ... the Arizona Grand in Phoenix. This beautiful all-suite hotel ... doorstep of the South Mountain Preserve. The Phoenix area ...
(Date:5/6/2015)... 2015 Dr. Vito C. Quatela, one of ... recently completed a medical mission trip to Hanoi, Vietnam with ... affected by microtia and other deformities of the face. , ... ended on April 26, Dr. Quatela and his team performed ... congenital deformity where the outside of the ear is underdeveloped. ...
(Date:5/6/2015)... Topical BioMedics, Inc., announces its May Pain Management Webinar will ... streamed live and then archived and accessible on demand 24/7. ... clicking on the following link: http://bit.ly/PMW_FIBRO . ... the webinar, and questions may also be submitted in advance ... the May webinar is “What You need to Know about ...
(Date:5/6/2015)... The Florida Council on Compulsive Gambling, Inc. (FCCG), along ... Geriatric Education Center, Mental Health Association of Southeast Florida, ... Abuse, will hold its annual conference in Ft Lauderdale ... , This important event will address topics such as ... clinical training for problem gambling treatment services. “This ...
Breaking Medicine News(10 mins):Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2
... a night,s rest may be the cause, research finds , ... the body,s production of the hormone melatonin, potentially leading to ... people often have problems with sleep after a brain injury, ... these problems," study author Shantha Rajaratnam of Monash University in ...
... is available by prescription under trade name Xenical and ... -- Responding to reports of rare but sometimes severe ... announced revised labels for a widely used weight-loss drug. ... the trade name Xenical and over-the-counter as Alli. , ...
... idea of individualized therapies, experts say , WEDNESDAY, May 26 ... not two, but potentially tens of thousands of genetic mutations ... A sample from a lung tumor from a heavy smoker ... 27 issue of Nature . , "People in the ...
... of individualized therapies, experts say , WEDNESDAY, May 26 (HealthDay ... two, but potentially tens of thousands of genetic mutations which, ... sample from a lung tumor from a heavy smoker revealed ... issue of Nature . , "People in the field ...
... development of a fast, simple, inexpensive method for determining ... skin allergies in people -- a method that does ... ACS, Chemical Research in Toxicology , a monthly ... the existence of public sentiment against the use of ...
... 26, 2010) Joan W. Miller, M.D., the HMS Henry ... of ophthalmology at Massachusetts Eye and Ear Infirmary and the ... Martin Dean,s Leadership Award for the Advancement of Women Faculty. ... was initiated by Joseph Martin, former HMS dean, in 1998. ...
Cached Medicine News:Health News:Brain Injuries May Lead to Sleep Woes 2Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 2Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 3Health News:Single Lung Tumor Contains 50,000 Mutations 2Health News:Single Lung Tumor Contains 50,000 Mutated Genes 2Health News:Joan Miller, M.D., receives 2010 Leadership Award for the Advancement of Women Faculty 2
This Flex Goggle has a unique wrap around design which fits the contour of the face and brow for optimum coverage. The ratchet style temple hinge allows multiple adjustments in, out, up and down for...
... optical steel base metal with gold electro-plate, ... durability. Includes adjustable non-slip silicon nose pads ... with custom fitted lead sheet side shields ... lenses for increased scatter radiation protection. (Temples ...
... of optical steel base ... Comes with custom fitted ... create a seal to ... increased scatter radiation protection. ...
... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...
Medicine Products: